Annual Retained Earnings
-$9.34 M
-$3.22 M-52.72%
December 31, 2023
Summary
- As of February 23, 2025, GDTC annual retained earnings is -$9.34 million, with the most recent change of -$3.22 million (-52.72%) on December 31, 2023.
- During the last 3 years, GDTC annual retained earnings has fallen by -$7.06 million (-309.63%).
- GDTC annual retained earnings is now -309.63% below its all-time high of -$2.28 million, reached on December 1, 2020.
Performance
GDTC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$9.89 M
-$553.00 K-5.92%
June 30, 2024
Summary
- As of February 23, 2025, GDTC quarterly retained earnings is -$9.89 million, with the most recent change of -$553.00 thousand (-5.92%) on June 30, 2024.
- Over the past year, GDTC quarterly retained earnings has dropped by -$2.25 million (-29.51%).
- GDTC quarterly retained earnings is now -163.91% below its all-time high of -$3.75 million, reached on December 31, 2021.
Performance
GDTC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
GDTC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.7% | -29.5% |
| 3 y3 years | -309.6% | -163.9% |
| 5 y5 years | -309.6% | -163.9% |
GDTC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -149.2% | at low | -163.9% | at low |
| 5 y | 5-year | -309.6% | at low | -163.9% | at low |
| alltime | all time | -309.6% | at low | -163.9% | at low |
CytoMed Therapeutics Limited Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -$9.89 M(+5.9%) |
| Dec 2023 | -$9.34 M(+52.7%) | -$9.34 M(+22.3%) |
| Jun 2023 | - | -$7.64 M(+24.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$6.11 M(+63.1%) | -$6.11 M(+40.5%) |
| Jun 2022 | - | -$4.35 M(+16.2%) |
| Dec 2021 | -$3.75 M(+64.4%) | -$3.75 M |
| Dec 2020 | -$2.28 M | - |
FAQ
- What is CytoMed Therapeutics Limited annual retained earnings?
- What is the all time high annual retained earnings for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual retained earnings year-on-year change?
- What is CytoMed Therapeutics Limited quarterly retained earnings?
- What is the all time high quarterly retained earnings for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly retained earnings year-on-year change?
What is CytoMed Therapeutics Limited annual retained earnings?
The current annual retained earnings of GDTC is -$9.34 M
What is the all time high annual retained earnings for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual retained earnings is -$2.28 M
What is CytoMed Therapeutics Limited annual retained earnings year-on-year change?
Over the past year, GDTC annual retained earnings has changed by -$3.22 M (-52.72%)
What is CytoMed Therapeutics Limited quarterly retained earnings?
The current quarterly retained earnings of GDTC is -$9.89 M
What is the all time high quarterly retained earnings for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly retained earnings is -$3.75 M
What is CytoMed Therapeutics Limited quarterly retained earnings year-on-year change?
Over the past year, GDTC quarterly retained earnings has changed by -$2.25 M (-29.51%)